Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
NUVBthis companyNuvation Bio Inc.	$4.27	-14.93×	10.01×	48.65×	-15.36×	-33.1%	86.6%	-338.7%	-325.3%	-66.9%	-41.0%	-5.7%	0.03×	0.81×	-15.57×	6.95×	0.0%	3	0.52	1	C-
CLDXCelldex Therapeutics, Inc.	$31.34	-6.96×	3.43×	1,204.09×	-6.97×	-99.2%	100.0%	-19160.0%	-17253.3%	-49.1%	-53.9%	-11.8%	0×	0.1×	0×	10.49×	0.0%	2	16.42	2	C
EWTXEdgewise Therapeutics, Inc.	$46.41	-15.23×	4.89×	0×	-15.09×	-98.7%	0.0%	0.0%	0.0%	-32.1%	-36.4%	-5.6%	0.01×	0.35×	0×	19.85×	0.0%	1	75.67	2	C
GPCRStructure Therapeutics Inc.	$21.57	-28.98×	2.72×	0×	-23.85×	-35.6%	0.0%	0.0%	0.0%	-9.3%	-18.9%	-5.5%	0×	5.69×	0×	24.81×	0.0%	1	9.92	2	C+
JANXJanux Therapeutics, Inc.	$13.05	-7.54×	0.89×	85.51×	-7.39×	-118.0%	79.7%	-1576.7%	-1136.3%	-11.9%	-16.0%	-9.7%	0.02×	0.27×	0×	39.04×	0.0%	3	8.27	2	C+
OCULOcular Therapeutix, Inc.	$6.57	-8.55×	3.47×	43.86×	-6.47×	-101.4%	87.3%	-521.0%	-513.2%	-40.6%	-35.5%	-9.5%	0.12×	2.63×	-22.82×	15.39×	0.0%	2	2.82	1	C-
Peer median	—	-8.55×	3.43×	43.86×	-7.39×	-99.2%	79.7%	-521.0%	-513.2%	-32.1%	-35.5%	-9.5%	0.01×	0.35×	0×	19.85×	0.0%	2	9.92	2	—